10.74
1.74%
-0.19
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
12.17%
7.639
|
6.81 | 5.762 | 5.95 | 5.433 |
Cost Of Revenue |
11.33%
3.114
|
2.797 | 2.489 | 2.824 | 2.231 |
Gross Profit |
12.76%
4.525
|
4.013 | 3.273 | 3.126 | 3.202 |
Operating Expenses
|
0.42%
8.756
|
8.719 | 8.17 | 10.26 | 8.914 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
3.07%
11.87
|
11.52 | 10.66 | 13.08 | 11.14 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
10.09%
-4.231
|
-4.706 | -4.897 | -7.131 | -5.712 |
Net Interest Income/Expense |
21.98%
0.111
|
0.091 | 0.10 | 0.081 | 0.114 |
Interest Income/Expense After Provision For Losses |
21.98%
0.111
|
0.091 | 0.10 | 0.081 | 0.114 |
Income/Loss From Continuing Operations Before Tax |
12.17%
7.639
|
6.81 | 5.762 | -7.052 | -5.609 |
Income/Loss From Continuing Operations After Tax |
10.24%
-4.146
|
-4.619 | -4.809 | -7.052 | -5.609 |
Net Income/Loss
|
10.24%
-4.146
|
-4.619 | -4.809 | -7.052 | -5.609 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
422.62K%
25.45
|
0.00602 | 24.63 | 24.58 | 24.58 |
Diluted Average Shares |
422.62K%
25.45
|
0.00602 | 24.63 | 24.58 | 24.58 |
Basic Earnings Per Share |
15.79%
-0.16
|
-0.19 | -0.20 | -0.29 | -0.23 |
Diluted Earnings Per Share |
15.79%
-0.16
|
-0.19 | -0.20 | -0.29 | -0.23 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):